Old Web
English
Sign In
Acemap
>
authorDetail
>
Chad Schwartzkopf
Chad Schwartzkopf
Novartis
Endocrinology
Internal medicine
Diabetes mellitus
Biology
Antagonist
3
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1081-P: Metabolic Effects of Praliciguat, Empagliflozin, and Their Combination in Rats with Programmed Hypertension and Early Exposure to High-Fat Diet
2020
Diabetes
Chad Schwartzkopf
Virginia Reverte Ribó
Francisca Rodríguez
Lidia Oltra
Juan Manuel Moreno Ayuso
M. Teresa Llinas
Alejandro S. Nicolas
Courtney Shea
Mark G. Currie
Juli E. Jones
Emmanuel S. Buys
Jaime L. Masferrer
Francisco Javier Salazar Aparicio
Show All
Source
Cite
Save
Citations (0)
124-LB: Praliciguat, a Clinical-Stage Soluble Guanylate Cyclase (sGC) Stimulator, Improved Oral Glucose and Lipid Handling and Slowed Diabetic Weight Loss in TALLYHO Mice
2020
Diabetes
Chad Schwartzkopf
Andrew Carvalho
John R. Hadcock
Mark G. Currie
Juli E. Jones
Show All
Source
Cite
Save
Citations (0)
Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity
2011
Naunyn-schmiedebergs Archives of Pharmacology
Laura H. Jacobson
S. Renee Commerford
Sarah P. Gerber
Yu Alice Chen
Beatriz N. Dardik
Frederique Chaperon
Chad Schwartzkopf
Van Nguyen-Tran
Thomas Hollenbeck
Peter McNamara
Xiaohui He
Hong Liu
H. Martin Seidel
Anneliese L. Jaton
Jesper Gromada
Sandra Teixeira
Show All
Source
Cite
Save
Citations (6)
1